Article
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
25 Jun 2022
Abstract excerpt
BACKGROUND: Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases (PF-ILD), including a few with sarcoidosis. To date, little is known about this progressive fibrosing phenotype in sarcoidosis. Diffusion capacity of carbon monoxide (DLCO) may be a useful functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
